BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 20600018)

  • 1. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers.
    Heald B; Mester J; Rybicki L; Orloff MS; Burke CA; Eng C
    Gastroenterology; 2010 Dec; 139(6):1927-33. PubMed ID: 20600018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations.
    Ngeow J; Mester J; Rybicki LA; Ni Y; Milas M; Eng C
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E2063-71. PubMed ID: 21956414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-specific loss of PTEN results in colorectal juvenile polyp formation and invasive cancer.
    Marsh Durban V; Jansen M; Davies EJ; Morsink FH; Offerhaus GJ; Clarke AR
    Am J Pathol; 2014 Jan; 184(1):86-91. PubMed ID: 24200851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonic manifestations of PTEN hamartoma tumor syndrome: case series and systematic review.
    Stanich PP; Pilarski R; Rock J; Frankel WL; El-Dika S; Meyer MM
    World J Gastroenterol; 2014 Feb; 20(7):1833-8. PubMed ID: 24587660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is colorectal surveillance indicated in patients with PTEN mutations?
    Nieuwenhuis MH; Kets CM; Murphy-Ryan M; Colas C; Möller P; Hes FJ; Hodgson SV; Olderode-Berends MJ; Aretz S; Heinimann K; Gomez Garcia EB; Douglas F; Spigelman A; Timshel S; Lindor NM; Vasen HF
    Colorectal Dis; 2012 Sep; 14(9):e562-6. PubMed ID: 22672595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal polyposis as a clue to the diagnosis of Cowden syndrome: Report of two cases and literature review.
    Innella G; Miccoli S; Colussi D; Pradella LM; Amato LB; Zuntini R; Salfi NCM; Collina G; Ferrara F; Ricciardiello L; Turchetti D
    Pathol Res Pract; 2021 Feb; 218():153339. PubMed ID: 33482532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis.
    Sweet K; Willis J; Zhou XP; Gallione C; Sawada T; Alhopuro P; Khoo SK; Patocs A; Martin C; Bridgeman S; Heinz J; Pilarski R; Lehtonen R; Prior TW; Frebourg T; Teh BT; Marchuk DA; Aaltonen LA; Eng C
    JAMA; 2005 Nov; 294(19):2465-73. PubMed ID: 16287957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal Polyposis in Cowden Syndrome.
    Shaco-Levy R; Jasperson KW; Martin K; Samadder NJ; Burt RW; Ying J; Bronner MP
    J Clin Gastroenterol; 2017 Aug; 51(7):e60-e67. PubMed ID: 27661969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper and Lower Gastrointestinal Findings in PTEN Mutation-Positive Cowden Syndrome Patients Participating in an Active Surveillance Program.
    Levi Z; Baris HN; Kedar I; Niv Y; Geller A; Gal E; Gingold R; Morgenstern S; Baruch Y; Leach BH; Bronner MP; Eng C
    Clin Transl Gastroenterol; 2011 Nov; 2(11):e5. PubMed ID: 23238744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN hamartoma tumour syndrome: case report based on data from the Iranian hereditary colorectal cancer registry and literature review.
    Rahmatinejad Z; Goshayeshi L; Bergquist R; Goshayeshi L; Golabpour A; Hoseini B
    Diagn Pathol; 2023 Apr; 18(1):43. PubMed ID: 37016356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of Cowden syndrome diagnosed from multiple gastric polyposis.
    Ha M; Chung JW; Hahm KB; Kim YJ; Lee W; An J; Kim DK; Kim MG
    World J Gastroenterol; 2012 Feb; 18(8):861-4. PubMed ID: 22371648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifetime cancer risks in individuals with germline PTEN mutations.
    Tan MH; Mester JL; Ngeow J; Rybicki LA; Orloff MS; Eng C
    Clin Cancer Res; 2012 Jan; 18(2):400-7. PubMed ID: 22252256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer risk and genotype-phenotype correlation in Japanese patients with Cowden syndrome.
    Teramae S; Muguruma N; Okamoto K; Oseto K; Nishikawa R; Tanoue T; Hirata K; Yanai S; Matsumoto T; Shimizu S; Miwa J; Sasaki Y; Yashima K; Ohnuma H; Sato Y; Kitayama Y; Ohda Y; Yamauchi A; Sanomura Y; Tanaka K; Kubo Y; Ishikawa H; Bando Y; Sonoda T; Takayama T
    Int J Clin Oncol; 2022 Apr; 27(4):639-647. PubMed ID: 35106660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?
    Mester JL; Moore RA; Eng C
    Oncologist; 2013; 18(10):1083-90. PubMed ID: 24037976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic Findings in Patients With PTEN Hamartoma Tumor Syndrome Undergoing Surveillance.
    Khare A; Burke CA; Heald B; O'Malley M; LaGuardia L; Milicia S; Cruise M; Eng C; Mankaney G
    J Clin Gastroenterol; 2022 Mar; 56(3):e183-e188. PubMed ID: 34231499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonic polyposis and neoplasia in Cowden syndrome.
    Stanich PP; Owens VL; Sweetser S; Khambatta S; Smyrk TC; Richardson RL; Goetz MP; Patnaik MM
    Mayo Clin Proc; 2011 Jun; 86(6):489-92. PubMed ID: 21628613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations.
    Sherman SK; Maxwell JE; Qian Q; Bellizzi AM; Braun TA; Iannettoni MD; Darbro BW; Howe JR
    Cancer Genet; 2015; 208(1-2):41-6. PubMed ID: 25554686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features.
    Pilarski R; Stephens JA; Noss R; Fisher JL; Prior TW
    J Med Genet; 2011 Aug; 48(8):505-12. PubMed ID: 21659347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal polyposis with esophageal polyposis is useful for early diagnosis of Cowden's disease.
    Umemura K; Takagi S; Ishigaki Y; Iwabuchi M; Kuroki S; Kinouchi Y; Shimosegawa T
    World J Gastroenterol; 2008 Oct; 14(37):5755-9. PubMed ID: 18837096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
    Ngeow J; Sesock K; Eng C
    Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.